ThinkMedTek

1. B-Secur and Galen Data have partnered to advance cardiac health monitoring technology. This collaboration integrates B-Secur’s HeartKey ECG algorithms with Galen Data’s cloud platform, enhancing real-time cardiac monitoring and data management for device manufacturers, aiming to revolutionize patient care in the growing cardiac monitoring market.
2. Microbot Medical has received FDA approval to begin its pivotal human clinical trial for the LIBERTY® Endovascular Robotic Surgical System. This trial, conducted in the U.S., aims to support a future 510(k) submission and will involve multiple leading medical centers.
3. Boston Scientific’s TheraSphere, tiny radioactive glass beads smaller than a human hair, deliver targeted radiation therapy to liver tumors via microcatheter. The technology, originally licensed from the University of Missouri, has received FDA approval and is being explored for treating other cancers, including brain cancer.
4. CERo Therapeutics has completed the toxicology studies for its lead compound, CER-1236, deemed essential for its Investigational New Drug (IND) application. The company is now focusing on ensuring compliant manufacturing procedures before submitting the IND to the FDA to begin human Phase 1 trials. 
5. Abbott has received CE Mark approval for its Aveir dual-chamber leadless pacemaker system, making it the first system of its kind approved for use in Europe. The device, designed to treat abnormal heart rhythms, allows for synchronized pacing of both the right atrium and right ventricle without the need for traditional leads.

Sources

1. https://www.med-technews.com/news/Digital-in-Healthcare-News/b-secur-and-galen-data-forge-partnership-for-next-generation-cardiac-health-monitoring/
2. https://www.mddionline.com/robotics/microbot-robotic-surgical-system-fda-approved-to-begin-human-trials
3. https://www.medicaldesignandoutsourcing.com/boston-scientific-therasphere-radiation-oncology-cancer-treatment/
4. https://infomeddnews.com/cero-therapeutics-news-6624/
5. https://www.medicaldesigndevelopment.com/home/news/22912013/abbott-gets-ce-mark-for-dual-chamber-leadless-pacemaker-system